Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Zydus enters global biologics CDMO market with $75m Agenus facility acquisitions

Summary by BioProcess International
The deal includes exclusive manufacturing rights for Agenus's cancer immunotherapies.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BioProcess InternationalBioProcess International

Zydus enters global biologics CDMO market with $75m Agenus facility acquisitions

The deal includes exclusive manufacturing rights for Agenus's cancer immunotherapies.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BioProcess International broke the news on Thursday, June 5, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer icon

Cancer

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal